Overview

Cysteamine for Asthma

Status:
Completed

Trial end date:
2021-02-10

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if a medicine called Cysteamine, given along with standard asthma care, will improve asthma symptoms and lung function.

Phase:

Phase 1

Details

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Treatments:

Cysteamine